Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Liabilities: 2019-2025

Historic Total Liabilities for Burning Rock Biotech (BNR) over the last 1 years, with Jun 2025 value amounting to $260.7 million.

  • Burning Rock Biotech's Total Liabilities was N/A to $260.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $401.1 million, marking a year-over-year change of. This contributed to the annual value of $41.7 million for FY2024, which is 9.05% up from last year.
  • According to the latest figures from Q2 2025, Burning Rock Biotech's Total Liabilities is $260.7 million, which was up 524.96% from $41.7 million recorded in Q4 2024.
  • In the past 5 years, Burning Rock Biotech's Total Liabilities ranged from a high of $260.7 million in Q2 2025 and a low of $38.3 million during Q4 2023.
  • Over the past 3 years, Burning Rock Biotech's median Total Liabilities value was $41.7 million (recorded in 2024), while the average stood at $113.6 million.
  • Per our database at Business Quant, Burning Rock Biotech's Total Liabilities skyrocketed by 83.30% in 2021 and then tumbled by 38.52% in 2023.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Total Liabilities stood at $68.0 million in 2021, then fell by 8.49% to $62.2 million in 2022, then tumbled by 38.52% to $38.3 million in 2023, then increased by 9.05% to $41.7 million in 2024, then reached $260.7 million in 2025.
  • Its Total Liabilities stands at $260.7 million for Q2 2025, versus $41.7 million for Q4 2024 and $38.3 million for Q4 2023.